Pages that link to "Q38540306"

The following pages link to Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders (Q38540306):

Displaying 27 items.

• An Update of Microsomal Prostaglandin E Synthase-1 and PGE2 Receptors in Cardiovascular Health and Diseases (Q28067884) (← links)
• A dynamic Asp-Arg interaction is essential for catalysis in microsomal prostaglandin E2 synthase. (Q36551582) (← links)
• Cardiovascular Consequences of Prostanoid I Receptor Deletion in Microsomal Prostaglandin E Synthase-1-Deficient Hyperlipidemic Mice (Q37131539) (← links)
• Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside (Q37340703) (← links)
• Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety (Q38558587) (← links)
• Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory pain (Q39007494) (← links)
• Microsomal prostaglandin E2 synthase-1 inhibitors: a patent review (Q39382626) (← links)
• Toxicity Thresholds for Diclofenac, Acetaminophen and Ibuprofen in the Water Flea Daphnia magna (Q39836164) (← links)
• Virtual screening and biological evaluation of novel antipyretic compounds. (Q40061945) (← links)
• Inhibition of microsomal PGE synthase-1 reduces human vascular tone by increasing PGI2 : a safer alternative to COX-2 inhibition (Q40147919) (← links)
• Microsomal Prostaglandin E Synthase-1 Expression in Inflammatory Conditions Is Downregulated by Dexamethasone: Seminal Role of the Regulatory Phosphatase MKP-1. (Q41819611) (← links)
• Inhibition of microsomal prostaglandin E-synthase-1 (mPGES-1) selectively suppresses PGE2 in an in vitro equine inflammation model (Q44876264) (← links)
• PDE4 inhibitor rolipram inhibits the expression of microsomal prostaglandin E synthase-1 by a mechanism dependent on MAP kinase phosphatase-1. (Q47103017) (← links)
• Computational models for the classification of mPGES-1 inhibitors with fingerprint descriptors (Q47830210) (← links)
• Deficiency of mPGES-1 exacerbates renal fibrosis and inflammation in mice with unilateral ureteral obstruction (Q48038002) (← links)
• Anti-inflammatory and analgesic activity of carnosol and carnosic acid in vivo and in vitro and in silico analysis of their target interactions. (Q54982673) (← links)
• Structure-based discovery of mPGES-1 inhibitors suitable for preclinical testing in wild-type mice as a new generation of anti-inflammatory drugs. (Q55380925) (← links)
• CRISPR/Cas9-based liver-derived reporter cells for screening of mPGES-1 inhibitors (Q64080713) (← links)
• A Combinatorial Virtual Screening Approach Driving the Synthesis of 2,4-Thiazolidinedione-Based Molecules as New Dual mPGES-1/5-LO Inhibitors (Q89543340) (← links)
• Viscosine as a Potent and Safe Antipyretic Agent Evaluated by Yeast-Induced Pyrexia Model and Molecular Docking Studies (Q90054353) (← links)
• Targeting the COX/mPGES-1/PGE2 Pathway in Neuroblastoma (Q90341470) (← links)
• Long-Lasting Anti-Inflammatory and Antinociceptive Effects of Acute Ammonium Glycyrrhizinate Administration: Pharmacological, Biochemical, and Docking Studies (Q91657718) (← links)
• Buzhongyiqi Decoction Protects Against Loperamide-Induced Constipation by Regulating the Arachidonic Acid Pathway in Rats (Q92132102) (← links)
• Ginkgolic Acid is a Multi-Target Inhibitor of Key Enzymes in Pro-Inflammatory Lipid Mediator Biosynthesis (Q92403172) (← links)
• Marine Alga Ecklonia cava Extract and Dieckol Attenuate Prostaglandin E2 Production in HaCaT Keratinocytes Exposed to Airborne Particulate Matter (Q92989911) (← links)
• Polysubstituted Pyrimidines as mPGES-1 Inhibitors: Discovery of Potent Inhibitors of PGE2 Production with a Strong Anti-inflammatory Effects in Carrageenan-Induced Rat Paw Edema (Q94915326) (← links)
• DREAM-in-CDM Approach and Identification of a New Generation of Anti-inflammatory Drugs Targeting mPGES-1 (Q96640272) (← links)